# Letrozole as a Treatment of Endometrial Cancer

> **NCT00997373** · NA · COMPLETED · sponsor: **University of California, Davis** · enrollment: 43 (actual)

## Conditions studied

- Endometrial Carcinoma

## Interventions

- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT00997373
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997373, "Letrozole as a Treatment of Endometrial Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00997373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*